We are live on ! Find out more
MESO

Mesoblast

22 hedge funds and large institutions have $14.3M invested in Mesoblast in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.02% less ownership

Funds ownership: 0.29%0.27% (-0.02%)

11% less capital invested

Capital invested by funds: $16M → $14.3M (-$1.75M)

24% less funds holding

Funds holding: 2922 (-7)

33% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 6

86% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 7

Holders
22
Holders Change
-7
Holders Change %
-24.14%
% of All Funds
0.5%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
4
Reduced
6
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
ARTA
26
A.R.T. Advisors
New York
-$68K -5,959 Closed
JP Morgan Chase
27
JP Morgan Chase
New York
-$45K -3,891 Closed
UBS Group
28
UBS Group
Switzerland
-$15K -1,322 Closed

MESO Hedge Fund Activity: Q2 2018 in Review

22 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Mesoblast (MESO) for Q2 2018, worth a combined $14.3M — down 11% from $16M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of MESO and 1 opened new positions — a net loss of 6 holders — while 6 trimmed existing stakes and 4 added.

The largest buyer was Wells Fargo, adding an estimated $30.4K. The largest seller was Renaissance Technologies, cutting an estimated $188K.

  • 22 institutional investors held Mesoblast (MESO) as of Q2 2018, down from 29 in Q1 2018.
  • Funds reported $14.3M of Mesoblast stock for Q2 2018, down 11% quarter-over-quarter.
  • 1 fund opened new Mesoblast positions in Q2 2018 and 7 closed out, a net change of -6 holders.
  • The largest Mesoblast buyer in Q2 2018 was Wells Fargo, an estimated $30.4K added.
  • The largest Mesoblast seller in Q2 2018 was Renaissance Technologies, an estimated $188K sold.

Based on aggregated 13F filings for Q2 2018.